Study on the clinical effects of Salicylazosul fapyridinum combined with Peifei-kang in patients with ulcerative colitis

Chuanyong Guo
2007-01-01
Abstract:Objective To evaluate the therapeutic effects of Salicylazosul fapyridinum combined with Pei-fei-kang in patients with ulcerative colitis.Methods Fifty-two patients with ulcerative colitis were divided into two groups randomly.27 cases in treated group received Salicylazosul fapyridinum combined with Pei-fei-kang therapy;25 cases in control group were only received Salicylazosul fapyridinum therapy.Patients were evaluated for the therapeutic effects.Results Before therapy,clinical activity index of treated groups was 7.85±2.93,while control group was 7.68±2.88.Two groups have no difference(P0.05).After treatment,the treated group was 1.56±1.78 as compared to 3.64±2.50 in control group.Clinical activity index in both groups were significantly decreased(P0.001),but the improvement of treatment group was better(P0.05).After treatment,clinical general therapeutic effect of cure、improved and failure in patients in treatment group were 20、5、2,and total effective percentage was 92.6% as compared with 11、6、8,total effective percentage of 68% in control group.Clinical general therapeutic effects of treatment group were better than that of the control group.The total remission percentage and total effective percentage were significantly different in two groups(P0.05).Conclusion Salicylazosul fapyridinum in combination with Pei-fei-kang,an enteric microflosa mediator therapy is helpful to improve their efficacy.
What problem does this paper attempt to address?